Bio Lab Naturals, Inc. Reports First Quarter Sales and Earnings

TAMPA, FL, Jul 11, 2011 (MARKETWIRE via COMTEX) -- Bio Lab Naturals, Inc. (pinksheets:BLAB) issued a report of sales and earnings for its first quarter ended March 31, 2011. Sales for the quarter were $ 777,213 compared to $ 378,143 a year earlier, an increase of 105% quarter on quarter. Net income for the first quarter ended March 31, 2011 was $281,397 compared to $50,409 for a year earlier, an increase of 558% quarter on quarter. BLAB President and CEO James L. Powers announced the results and advised that "we are pleased and excited with our progress in the operational integration of Ribbon Naturals Corporation with BLAB. Our combined personnel and resources are facilitating new products development, and weanticipate launching a series of new products during the third and fourth quarters of this year into both the anti-aging and athletic performance markets."

ABOUT BIO LAB NATURALS, INC.

Bio Lab Naturals, Inc. (pinksheets:BLAB) is a nutraceutical company with multiple product offerings built upon our proprietary specialized protein extract derived from deer velvet antler. We have products focused on specific health professional and retail markets with sales being driven by online promotion as well as print marketing followed by direct contact with buyers for stores or user groups. We are vertical in our operations with product development, in-house graphics for packaging and promotion, call center operations for both in-bound and out-bound sales along with shipping and fulfillment services. For more information, please visit www.biolabnaturals.com or call Malcolm Davenport at 706-773-4445.

This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the statements made herein.

Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

Contact:
Malcolm Davenport
Investor Relations
www.biolabnaturals.com
706-773-4445

SOURCE: Bio Lab Naturals, Inc.

http://www.biolabnaturals.com/

Copyright 2011 Marketwire, Inc., All rights reserved.